Canada markets open in 1 hour 6 minutes

Medigen Vaccine Biologics Corporation (6547.TWO)

Taipei Exchange - Taipei Exchange Delayed Price. Currency in TWD
Add to watchlist
52.30+0.70 (+1.36%)
At close: 01:30PM CST
Currency in TWD

Valuation Measures4

Market Cap (intraday) 16.96B
Enterprise Value 15.17B
Trailing P/E 56.42
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)43.52
Price/Book (mrq)4.41
Enterprise Value/Revenue 38.94
Enterprise Value/EBITDA -15.31

Trading Information

Stock Price History

Beta (5Y Monthly) 0.80
52-Week Change 3-18.74%
S&P500 52-Week Change 323.57%
52 Week High 381.50
52 Week Low 348.05
50-Day Moving Average 354.79
200-Day Moving Average 364.54

Share Statistics

Avg Vol (3 month) 31.41M
Avg Vol (10 day) 31.18M
Shares Outstanding 5328.61M
Implied Shares Outstanding 6331.77M
Float 8255.1M
% Held by Insiders 126.63%
% Held by Institutions 13.69%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21482.8058:1000
Last Split Date 3Aug 03, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -297.68%
Operating Margin (ttm)-318.57%

Management Effectiveness

Return on Assets (ttm)-11.29%
Return on Equity (ttm)-26.14%

Income Statement

Revenue (ttm)389.62M
Revenue Per Share (ttm)1.19
Quarterly Revenue Growth (yoy)622.00%
Gross Profit (ttm)N/A
EBITDA -1.1B
Net Income Avi to Common (ttm)-1.16B
Diluted EPS (ttm)-3.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.76B
Total Cash Per Share (mrq)11.43
Total Debt (mrq)1.97B
Total Debt/Equity (mrq)51.33%
Current Ratio (mrq)2.21
Book Value Per Share (mrq)11.71

Cash Flow Statement

Operating Cash Flow (ttm)-478.34M
Levered Free Cash Flow (ttm)-164.31M